Pharvaris (PHVS) Assets Growth (1y) (2020 - 2026)
Pharvaris (PHVS) Assets Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Pharvaris | 2.17 Bn | 1.88 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.56% |
| Dec 31, 2025 | 12.70% |
| Sep 30, 2025 | 15.19% |
| Jun 30, 2025 | -37.32% |
| Mar 31, 2025 | -36.39% |
| Dec 31, 2024 | -27.42% |
| Sep 30, 2024 | 86.58% |
| Jun 30, 2024 | 83.38% |
| Mar 31, 2024 | 158.58% |
| Dec 31, 2023 | 150.67% |
| Sep 30, 2023 | -9.93% |
| Jun 30, 2023 | -6.34% |
| Mar 31, 2023 | -29.72% |
| Dec 31, 2022 | -29.47% |
| Sep 30, 2022 | -22.21% |
| Jun 30, 2022 | -20.26% |
| Mar 31, 2022 | -23.31% |
| Dec 31, 2021 | 101.28% |
| Dec 31, 2020 | 428.70% |